Mylan Gets Expert Panel Go-Ahead For Pretomanid In India

18:13 EST 13 Feb 2020 | SCRIP

Tuberculosis drug pretomanid gets endorsement, with Phase III trial waiver, from a key expert panel that advises India's drugs regulator...


Related Stories


Original Article: Mylan Gets Expert Panel Go-Ahead For Pretomanid In India


More From BioPortfolio on "Mylan Gets Expert Panel Go-Ahead For Pretomanid In India"

Quick Search

Relevant Topics

Tuberculosis TB
Tuberculosis (TB) is an infectious disease caused by bacteria belonging to the Mycobacterium tuberculosis complex. Over nine million new cases of TB, and nearly two million deaths from TB, are estimated to occur around the world every year, and new inf...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...